May 23, 2025
Ripretinib
Journal of Clinical Oncology

Updated Overall Survival and Long-Term Safety With Ripretinib Versus Sunitinib in Patients With GI Stromal Tumor: Final Overall Survival Analysis From INTRIGUE

For questions regarding any Deciphera publications, please contact medicalinformation@deciphera.com